Global Oral Contraceptive Sales Market Report 2021

Global Oral Contraceptive Sales Market Report 2021

Table of Contents
1 Oral Contraceptive Market Overview
1.1 Oral Contraceptive Product Scope
1.2 Oral Contraceptive Segment by Type
1.2.1 Global Oral Contraceptive Sales by Type (2016 & 2021 & 2027)
1.2.2 Combination
1.2.3 Progestin Only
1.2.4 Others
1.3 Oral Contraceptive Segment by Application
1.3.1 Global Oral Contraceptive Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Male
1.3.3 Female
1.4 Oral Contraceptive Market Estimates and Forecasts (2016-2027)
1.4.1 Global Oral Contraceptive Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Oral Contraceptive Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Oral Contraceptive Price Trends (2016-2027)
2 Oral Contraceptive Estimates and Forecasts by Region
2.1 Global Oral Contraceptive Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Oral Contraceptive Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Oral Contraceptive Sales Market Share by Region (2016-2021)
2.2.2 Global Oral Contraceptive Revenue Market Share by Region (2016-2021)
2.3 Global Oral Contraceptive Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Oral Contraceptive Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Oral Contraceptive Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Oral Contraceptive Estimates and Projections (2016-2027)
2.4.2 Europe Oral Contraceptive Estimates and Projections (2016-2027)
2.4.3 China Oral Contraceptive Estimates and Projections (2016-2027)
2.4.4 Japan Oral Contraceptive Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Oral Contraceptive Estimates and Projections (2016-2027)
2.4.6 India Oral Contraceptive Estimates and Projections (2016-2027)
3 Global Oral Contraceptive Competition Landscape by Players
3.1 Global Top Oral Contraceptive Players by Sales (2016-2021)
3.2 Global Top Oral Contraceptive Players by Revenue (2016-2021)
3.3 Global Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Contraceptive as of 2020)
3.4 Global Oral Contraceptive Average Price by Company (2016-2021)
3.5 Manufacturers Oral Contraceptive Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Oral Contraceptive Market Size by Type
4.1 Global Oral Contraceptive Historic Market Review by Type (2016-2021)
4.1.1 Global Oral Contraceptive Sales Market Share by Type (2016-2021)
4.1.2 Global Oral Contraceptive Revenue Market Share by Type (2016-2021)
4.1.3 Global Oral Contraceptive Price by Type (2016-2021)
4.2 Global Oral Contraceptive Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Oral Contraceptive Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Contraceptive Revenue Forecast by Type (2022-2027)
4.2.3 Global Oral Contraceptive Price Forecast by Type (2022-2027)
5 Global Oral Contraceptive Market Size by Application
5.1 Global Oral Contraceptive Historic Market Review by Application (2016-2021)
5.1.1 Global Oral Contraceptive Sales Market Share by Application (2016-2021)
5.1.2 Global Oral Contraceptive Revenue Market Share by Application (2016-2021)
5.1.3 Global Oral Contraceptive Price by Application (2016-2021)
5.2 Global Oral Contraceptive Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Oral Contraceptive Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Contraceptive Revenue Forecast by Application (2022-2027)
5.2.3 Global Oral Contraceptive Price Forecast by Application (2022-2027)
6 North America Oral Contraceptive Market Facts & Figures
6.1 North America Oral Contraceptive Sales by Company
6.1.1 North America Oral Contraceptive Sales by Company (2016-2021)
6.1.2 North America Oral Contraceptive Revenue by Company (2016-2021)
6.2 North America Oral Contraceptive Sales Breakdown by Type
6.2.1 North America Oral Contraceptive Sales Breakdown by Type (2016-2021)
6.2.2 North America Oral Contraceptive Sales Breakdown by Type (2022-2027)
6.3 North America Oral Contraceptive Sales Breakdown by Application
6.3.1 North America Oral Contraceptive Sales Breakdown by Application (2016-2021)
6.3.2 North America Oral Contraceptive Sales Breakdown by Application (2022-2027)
7 Europe Oral Contraceptive Market Facts & Figures
7.1 Europe Oral Contraceptive Sales by Company
7.1.1 Europe Oral Contraceptive Sales by Company (2016-2021)
7.1.2 Europe Oral Contraceptive Revenue by Company (2016-2021)
7.2 Europe Oral Contraceptive Sales Breakdown by Type
7.2.1 Europe Oral Contraceptive Sales Breakdown by Type (2016-2021)
7.2.2 Europe Oral Contraceptive Sales Breakdown by Type (2022-2027)
7.3 Europe Oral Contraceptive Sales Breakdown by Application
7.3.1 Europe 119 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 119 Sales Breakdown by Application (2022-2027)
8 China Oral Contraceptive Market Facts & Figures
8.1 China Oral Contraceptive Sales by Company
8.1.1 China Oral Contraceptive Sales by Company (2016-2021)
8.1.2 China Oral Contraceptive Revenue by Company (2016-2021)
8.2 China Oral Contraceptive Sales Breakdown by Type
8.2.1 China Oral Contraceptive Sales Breakdown by Type (2016-2021)
8.2.2 China Oral Contraceptive Sales Breakdown by Type (2022-2027)
8.3 China Oral Contraceptive Sales Breakdown by Application
8.3.1 China 142 Sales Breakdown by Application (2016-2021)
8.3.2 China 142 Sales Breakdown by Application (2022-2027)
9 Japan Oral Contraceptive Market Facts & Figures
9.1 Japan Oral Contraceptive Sales by Company
9.1.1 Japan Oral Contraceptive Sales by Company (2016-2021)
9.1.2 Japan Oral Contraceptive Revenue by Company (2016-2021)
9.2 Japan Oral Contraceptive Sales Breakdown by Type
9.2.1 Japan Oral Contraceptive Sales Breakdown by Type (2016-2021)
9.2.2 Japan Oral Contraceptive Sales Breakdown by Type (2022-2027)
9.3 Japan Oral Contraceptive Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Oral Contraceptive Market Facts & Figures
10.1 Southeast Asia Oral Contraceptive Sales by Company
10.1.1 Southeast Asia Oral Contraceptive Sales by Company (2016-2021)
10.1.2 Southeast Asia Oral Contraceptive Revenue by Company (2016-2021)
10.2 Southeast Asia Oral Contraceptive Sales Breakdown by Type
10.2.1 Southeast Asia Oral Contraceptive Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Oral Contraceptive Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Oral Contraceptive Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Oral Contraceptive Market Facts & Figures
11.1 India Oral Contraceptive Sales by Company
11.1.1 India Oral Contraceptive Sales by Company (2016-2021)
11.1.2 India Oral Contraceptive Revenue by Company (2016-2021)
11.2 India Oral Contraceptive Sales Breakdown by Type
11.2.1 India Oral Contraceptive Sales Breakdown by Type (2016-2021)
11.2.2 India Oral Contraceptive Sales Breakdown by Type (2022-2027)
11.3 India Oral Contraceptive Sales Breakdown by Application
11.3.1 India Oral Contraceptive Sales Breakdown by Application (2016-2021)
11.3.2 India Oral Contraceptive Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Oral Contraceptive Business
12.1 Pfizer, Inc.
12.1.1 Pfizer, Inc. Corporation Information
12.1.2 Pfizer, Inc. Business Overview
12.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer, Inc. Oral Contraceptive Products Offered
12.1.5 Pfizer, Inc. Recent Development
12.2 Bayer AG
12.2.1 Bayer AG Corporation Information
12.2.2 Bayer AG Business Overview
12.2.3 Bayer AG Oral Contraceptive Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer AG Oral Contraceptive Products Offered
12.2.5 Bayer AG Recent Development
12.3 Merck & Co., Inc.
12.3.1 Merck & Co., Inc. Corporation Information
12.3.2 Merck & Co., Inc. Business Overview
12.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck & Co., Inc. Oral Contraceptive Products Offered
12.3.5 Merck & Co., Inc. Recent Development
12.4 Janssen Global Services, LLC
12.4.1 Janssen Global Services, LLC Corporation Information
12.4.2 Janssen Global Services, LLC Business Overview
12.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Janssen Global Services, LLC Oral Contraceptive Products Offered
12.4.5 Janssen Global Services, LLC Recent Development
12.5 Mankind Pharma Ltd.
12.5.1 Mankind Pharma Ltd. Corporation Information
12.5.2 Mankind Pharma Ltd. Business Overview
12.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mankind Pharma Ltd. Oral Contraceptive Products Offered
12.5.5 Mankind Pharma Ltd. Recent Development
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.6.2 Teva Pharmaceutical Industries Ltd Business Overview
12.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Products Offered
12.6.5 Teva Pharmaceutical Industries Ltd Recent Development
12.7 Allergan, plc (Actavis)
12.7.1 Allergan, plc (Actavis) Corporation Information
12.7.2 Allergan, plc (Actavis) Business Overview
12.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Allergan, plc (Actavis) Oral Contraceptive Products Offered
12.7.5 Allergan, plc (Actavis) Recent Development
12.8 Piramal Enterprises Ltd.
12.8.1 Piramal Enterprises Ltd. Corporation Information
12.8.2 Piramal Enterprises Ltd. Business Overview
12.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Piramal Enterprises Ltd. Oral Contraceptive Products Offered
12.8.5 Piramal Enterprises Ltd. Recent Development
12.9 Beijing Zizhu Pharm
12.9.1 Beijing Zizhu Pharm Corporation Information
12.9.2 Beijing Zizhu Pharm Business Overview
12.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Beijing Zizhu Pharm Oral Contraceptive Products Offered
12.9.5 Beijing Zizhu Pharm Recent Development
13 Oral Contraceptive Manufacturing Cost Analysis
13.1 Oral Contraceptive Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oral Contraceptive
13.4 Oral Contraceptive Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oral Contraceptive Distributors List
14.3 Oral Contraceptive Customers
15 Market Dynamics
15.1 Oral Contraceptive Market Trends
15.2 Oral Contraceptive Drivers
15.3 Oral Contraceptive Market Challenges
15.4 Oral Contraceptive Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Oral Contraceptive Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Oral Contraceptive Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Oral Contraceptive Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Oral Contraceptive Sales (K Units) by Region (2016-2021)
Table 5. Global Oral Contraceptive Sales Market Share by Region (2016-2021)
Table 6. Global Oral Contraceptive Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Oral Contraceptive Revenue Share by Region (2016-2021)
Table 8. Global Oral Contraceptive Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Oral Contraceptive Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Oral Contraceptive Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Oral Contraceptive Revenue Share Forecast by Region (2022-2027)
Table 12. Global Oral Contraceptive Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Oral Contraceptive Sales Share by Company (2016-2021)
Table 14. Global Oral Contraceptive Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Oral Contraceptive Revenue Share by Company (2016-2021)
Table 16. Global Oral Contraceptive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Contraceptive as of 2020)
Table 17. Global Oral Contraceptive Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Oral Contraceptive Manufacturing Sites and Area Served
Table 19. Manufacturers Oral Contraceptive Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Oral Contraceptive Sales (K Units) by Type (2016-2021)
Table 22. Global Oral Contraceptive Sales Share by Type (2016-2021)
Table 23. Global Oral Contraceptive Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Oral Contraceptive Price (USD/Unit) by Type (2016-2021)
Table 25. Global Oral Contraceptive Sales Share by Type (2022-2027)
Table 26. Global Oral Contraceptive Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Oral Contraceptive Revenue Share by Type (2022-2027)
Table 28. Global Oral Contraceptive Price (USD/Unit) by Type (2022-2027)
Table 29. Global Oral Contraceptive Sales (K Units) by Application (2016-2021)
Table 30. Global Oral Contraceptive Sales Share by Application (2016-2021)
Table 31. Global Oral Contraceptive Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Oral Contraceptive Price (USD/Unit) by Application (2016-2021)
Table 33. Global Oral Contraceptive Sales (K Units) by Application (2022-2027)
Table 34. Global Oral Contraceptive Sales Share by Application (2022-2027)
Table 35. Global Oral Contraceptive Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Oral Contraceptive Revenue Share by Application (2022-2027)
Table 37. Global Oral Contraceptive Price (USD/Unit) by Application (2022-2027)
Table 38. North America Oral Contraceptive Sales (K Units) by Company (2016-2021)
Table 39. North America Oral Contraceptive Sales Market Share by Company (2016-2021)
Table 40. North America Oral Contraceptive Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Oral Contraceptive Revenue Market Share by Company (2016-2021)
Table 42. North America Oral Contraceptive Sales by Type (2016-2021) & (K Units)
Table 43. North America Oral Contraceptive Sales Market Share by Type (2016-2021)
Table 44. North America Oral Contraceptive Sales by Type (2022-2027) & (K Units)
Table 45. North America Oral Contraceptive Sales Market Share by Type (2022-2027)
Table 46. North America Oral Contraceptive Sales by Application (2016-2021) & (K Units)
Table 47. North America Oral Contraceptive Sales Market Share by Application (2016-2021)
Table 48. North America Oral Contraceptive Sales by Application (2022-2027) & (K Units)
Table 49. North America Oral Contraceptive Sales Market Share by Application (2022-2027)
Table 50. Europe Oral Contraceptive Sales (K Units) by Company (2016-2021)
Table 51. Europe Oral Contraceptive Sales Market Share by Company (2016-2021)
Table 52. Europe Oral Contraceptive Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Oral Contraceptive Revenue Market Share by Company (2016-2021)
Table 54. Europe Oral Contraceptive Sales by Type (2016-2021) & (K Units)
Table 55. Europe Oral Contraceptive Sales Market Share by Type (2016-2021)
Table 56. Europe Oral Contraceptive Sales by Type (2022-2027) & (K Units)
Table 57. Europe Oral Contraceptive Sales Market Share by Type (2022-2027)
Table 58. Europe Oral Contraceptive Sales by Application (2016-2021) & (K Units)
Table 59. Europe Oral Contraceptive Sales Market Share by Application (2016-2021)
Table 60. Europe Oral Contraceptive Sales by Application (2022-2027) & (K Units)
Table 61. Europe Oral Contraceptive Sales Market Share by Application (2022-2027)
Table 62. China Oral Contraceptive Sales (K Units) by Company (2016-2021)
Table 63. China Oral Contraceptive Sales Market Share by Company (2016-2021)
Table 64. China Oral Contraceptive Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Oral Contraceptive Revenue Market Share by Company (2016-2021)
Table 66. China Oral Contraceptive Sales by Type (2016-2021) & (K Units)
Table 67. China Oral Contraceptive Sales Market Share by Type (2016-2021)
Table 68. China Oral Contraceptive Sales by Type (2022-2027) & (K Units)
Table 69. China Oral Contraceptive Sales Market Share by Type (2022-2027)
Table 70. China Oral Contraceptive Sales by Application (2016-2021) & (K Units)
Table 71. China Oral Contraceptive Sales Market Share by Application (2016-2021)
Table 72. China Oral Contraceptive Sales by Application (2022-2027) & (K Units)
Table 73. China Oral Contraceptive Sales Market Share by Application (2022-2027)
Table 74. Japan Oral Contraceptive Sales (K Units) by Company (2016-2021)
Table 75. Japan Oral Contraceptive Sales Market Share by Company (2016-2021)
Table 76. Japan Oral Contraceptive Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Oral Contraceptive Revenue Market Share by Company (2016-2021)
Table 78. Japan Oral Contraceptive Sales by Type (2016-2021) & (K Units)
Table 79. Japan Oral Contraceptive Sales Market Share by Type (2016-2021)
Table 80. Japan Oral Contraceptive Sales by Type (2022-2027) & (K Units)
Table 81. Japan Oral Contraceptive Sales Market Share by Type (2022-2027)
Table 82. Japan Oral Contraceptive Sales by Application (2016-2021) & (K Units)
Table 83. Japan Oral Contraceptive Sales Market Share by Application (2016-2021)
Table 84. Japan Oral Contraceptive Sales by Application (2022-2027) & (K Units)
Table 85. Japan Oral Contraceptive Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Oral Contraceptive Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Oral Contraceptive Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Oral Contraceptive Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Oral Contraceptive Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Oral Contraceptive Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Oral Contraceptive Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Oral Contraceptive Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Oral Contraceptive Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Oral Contraceptive Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Oral Contraceptive Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Oral Contraceptive Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Oral Contraceptive Sales Market Share by Application (2022-2027)
Table 98. India Oral Contraceptive Sales (K Units) by Company (2016-2021)
Table 99. India Oral Contraceptive Sales Market Share by Company (2016-2021)
Table 100. India Oral Contraceptive Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Oral Contraceptive Revenue Market Share by Company (2016-2021)
Table 102. India Oral Contraceptive Sales by Type (2016-2021) & (K Units)
Table 103. India Oral Contraceptive Sales Market Share by Type (2016-2021)
Table 104. India Oral Contraceptive Sales by Type (2022-2027) & (K Units)
Table 105. India Oral Contraceptive Sales Market Share by Type (2022-2027)
Table 106. India Oral Contraceptive Sales by Application (2016-2021) & (K Units)
Table 107. India Oral Contraceptive Sales Market Share by Application (2016-2021)
Table 108. India Oral Contraceptive Sales by Application (2022-2027) & (K Units)
Table 109. India Oral Contraceptive Sales Market Share by Application (2022-2027)
Table 110. Pfizer, Inc. Corporation Information
Table 111. Pfizer, Inc. Description and Business Overview
Table 112. Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer, Inc. Oral Contraceptive Product
Table 114. Pfizer, Inc. Recent Development
Table 115. Bayer AG Corporation Information
Table 116. Bayer AG Description and Business Overview
Table 117. Bayer AG Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Bayer AG Oral Contraceptive Product
Table 119. Bayer AG Recent Development
Table 120. Merck & Co., Inc. Corporation Information
Table 121. Merck & Co., Inc. Description and Business Overview
Table 122. Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Merck & Co., Inc. Oral Contraceptive Product
Table 124. Merck & Co., Inc. Recent Development
Table 125. Janssen Global Services, LLC Corporation Information
Table 126. Janssen Global Services, LLC Description and Business Overview
Table 127. Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Janssen Global Services, LLC Oral Contraceptive Product
Table 129. Janssen Global Services, LLC Recent Development
Table 130. Mankind Pharma Ltd. Corporation Information
Table 131. Mankind Pharma Ltd. Description and Business Overview
Table 132. Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Mankind Pharma Ltd. Oral Contraceptive Product
Table 134. Mankind Pharma Ltd. Recent Development
Table 135. Teva Pharmaceutical Industries Ltd Corporation Information
Table 136. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 137. Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Teva Pharmaceutical Industries Ltd Oral Contraceptive Product
Table 139. Teva Pharmaceutical Industries Ltd Recent Development
Table 140. Allergan, plc (Actavis) Corporation Information
Table 141. Allergan, plc (Actavis) Description and Business Overview
Table 142. Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Allergan, plc (Actavis) Oral Contraceptive Product
Table 144. Allergan, plc (Actavis) Recent Development
Table 145. Piramal Enterprises Ltd. Corporation Information
Table 146. Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Piramal Enterprises Ltd. Description and Business Overview
Table 148. Piramal Enterprises Ltd. Oral Contraceptive Product
Table 149. Piramal Enterprises Ltd. Recent Development
Table 150. Beijing Zizhu Pharm Corporation Information
Table 151. Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Beijing Zizhu Pharm Description and Business Overview
Table 153. Beijing Zizhu Pharm Oral Contraceptive Product
Table 154. Beijing Zizhu Pharm Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Oral Contraceptive Distributors List
Table 158. Oral Contraceptive Customers List
Table 159. Oral Contraceptive Market Trends
Table 160. Oral Contraceptive Market Drivers
Table 161. Oral Contraceptive Market Challenges
Table 162. Oral Contraceptive Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Contraceptive Product Picture
Figure 2. Global Oral Contraceptive Sales Market Share by Type in 2021 & 2027
Figure 3. Combination Product Picture
Figure 4. Progestin Only Product Picture
Figure 5. Others Product Picture
Figure 6. Global Oral Contraceptive Sales Market Share by Application in 2021 & 2027
Figure 7. Male Examples
Figure 8. Female Examples
Figure 9. Global Oral Contraceptive Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Oral Contraceptive Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Oral Contraceptive Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Oral Contraceptive Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Oral Contraceptive Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Oral Contraceptive Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Oral Contraceptive Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Oral Contraceptive Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Oral Contraceptive Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Oral Contraceptive Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Oral Contraceptive Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Oral Contraceptive Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Oral Contraceptive Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Oral Contraceptive Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Oral Contraceptive Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Oral Contraceptive Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Oral Contraceptive Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Oral Contraceptive Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Oral Contraceptive Players Market Share by Revenue in Oral Contraceptive: 2016 & 2020
Figure 28. Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Oral Contraceptive Revenue Share by Type (2016-2021)
Figure 30. Global Oral Contraceptive Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Oral Contraceptive Revenue Share by Application (2016-2021)
Figure 32. Global Oral Contraceptive Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Oral Contraceptive Sales Market Share by Type in 2020
Figure 34. North America Oral Contraceptive Sales Market Share by Application in 2020
Figure 35. Europe Oral Contraceptive Sales Market Share by Type in 2020
Figure 36. Europe Oral Contraceptive Sales Market Share by Application in 2020
Figure 37. China Oral Contraceptive Sales Market Share by Type in 2020
Figure 38. China Oral Contraceptive Sales Market Share by Application in 2020
Figure 39. Japan Oral Contraceptive Sales Market Share by Type in 2020
Figure 40. Japan Oral Contraceptive Sales Market Share by Application in 2020
Figure 41. Southeast Asia Oral Contraceptive Sales Market Share by Type in 2020
Figure 42. Southeast Asia Oral Contraceptive Sales Market Share by Application in 2020
Figure 43. India Oral Contraceptive Sales Market Share by Type in 2020
Figure 44. India Oral Contraceptive Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Oral Contraceptive
Figure 47. Manufacturing Process Analysis of Oral Contraceptive
Figure 48. Oral Contraceptive Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......

Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......

Global Contraceptives Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141

According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......

Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......

Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......

Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139

Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122

Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......

Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......

Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs